SOLV · Solventum Corporation
Healthcare NYQ United States solventum.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/S1.86 P/E Fwd P/E12.49 PEG1.22 52W –  RSI Target$84.69 (-4.4%) Beta0.72 Div
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Eagan, United States 20,584 employees
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 72 Overbought · 100
Signal Overbought
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
0Bearish
0Neutral
▲ Bull Flag — Breakout after +8% pole — bullish continuation
▲ Bull Flag — Breakout after +13% pole — bullish continuation
▲ Double Bottom — Two lows ~$73.90 — bullish reversal confirmed

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 05, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside -4.4%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
8
5
2
BuyHoldSell
Price Target Range
$84.69 -4.4% upside
Low $60 High $100
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
UBS Buy Neutral Buy ▲ Upgrade 2026-07-28
BMO Capital Market Perform ● Initiate 2026-07-09
Wedbush Outperform ● Initiate 2026-05-15
Stifel Buy ↔ Maintain 2026-05-06
Wells Fargo Equal-Weight ↔ Maintain 2026-05-06
Keybanc Overweight ↔ Maintain 2026-05-06
BTIG Buy ↔ Reiterate 2026-05-06
Piper Sandler Overweight ↔ Maintain 2026-04-17
Rothschild & Co Sell ● Initiate 2026-03-24
Mizuho Outperform Neutral Outperform ▲ Upgrade 2026-01-20
UBS 2026-07-28
Buy (from Neutral) ▲ Upgrade
BMO Capital 2026-07-09
Market Perform ● Initiate
Wedbush 2026-05-15
Outperform ● Initiate
Stifel 2026-05-06
Buy ↔ Maintain
Wells Fargo 2026-05-06
Equal-Weight ↔ Maintain
Keybanc 2026-05-06
Overweight ↔ Maintain
BTIG 2026-05-06
Buy ↔ Reiterate
Piper Sandler 2026-04-17
Overweight ↔ Maintain
Rothschild & Co 2026-03-24
Sell ● Initiate
Mizuho 2026-01-20
Outperform (from Neutral) ▲ Upgrade
Profitability
Gross Margin 53.65%TTM
Op. Margin 5.58%TTM
ROE 34.79%TTM
Rev. Growth -3.00%YoY
Free Cash Flow 377.50MTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 106.48MRQ
Current Ratio 1.07MRQ
Cash 561.00MMRQ
Total Debt 5.29BMRQ
Net Debt MRQ
How SOLV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap15.33B
Enterprise Value20.06B
Trailing P/E10.55
Forward P/E12.49
PEG Ratio (5yr)1.22
Price/Sales (ttm)1.86
Price/Book (mrq)3.09
EV/Revenue2.43
EV/EBITDA17.85
Share Statistics
Avg Vol (3m)1.70M
Shares Outstanding173.17M
Float147.07M
% Held by Insiders15.07%
% Held by Institutions76.31%
Short Ratio3.34
Short % of Float2.92%
Profitability
Gross Margin53.65%
Operating Margin (ttm)5.58%
Profit Margin17.33%
Return on Assets (ttm)2.75%
Return on Equity (ttm)34.79%
Income Statement
Revenue (ttm)8.26B
Revenue Growth (yoy)-3.00%
Gross Profit (ttm)4.43B
EBITDA1.12B
Net Income (ttm)1.43B
Diluted EPS (ttm)8.39
EPS Growth (yoy)-91.00%
Balance Sheet
Total Cash (mrq)561.00M
Total Debt (mrq)5.29B
Debt / Equity (mrq)106.48
Current Ratio (mrq)1.07
Book Value / Share28.64
Operating CF (ttm)151.00M
Free Cash Flow (ttm)377.50M
Trading & Dividends
Beta (5Y)0.72
50-Day MA77.94
200-Day MA75.11
Fwd Dividend YieldN/A
Payout Ratio0.00%
Ownership Breakdown
Institutional 76.31% Insider 15.07% Public 8.6%
Short Interest 2.92% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in SOLV in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-05-13 MCMILLAN WAYDE D Chief Financial Officer 9,503
2026-05-13 HANSON BRYAN CRAIG Chief Executive Officer 34,315
2026-05-13 KIRBERGER MARCELA A. Officer 4,488
2026-05-13 GOMEZ TAMMY L Officer 3,960
2026-05-13 LANDUCCI AMY Chief Technology Officer 4,422
2026-05-13 WILCOX MARY T Officer 2,376
2026-05-13 HARRINGTON PAUL S Officer 3,960
2026-04-30 EISENBERG GLENN A Director 3,403
2026-04-30 HARRIS BERNARD A JR Director 3,403
2026-04-30 ALBAN CARLOS Director 3,403
2026-04-30 DEVORE SUSAN D Director 3,403
2026-04-30 WILSON DARRYL L Director 3,403
2026-04-30 MILY ELIZABETH Director 3,403
2026-04-30 WEILAND JOHN H Director 3,403
2026-04-30 COX CARRIE SMITH Director 4,916
2026-04-30 MAY KAREN J Director 3,403
2026-04-30 EDWARDS SHIRLEY ANN Director 3,403
2026-04-30 WENDELL AMY MCBRIDE Director 3,403
2026-03-27 EISENBERG GLENN A Director 1,980
2026-03-27 HARRIS BERNARD A JR Director 1,980
2026-03-27 MCBRIDE-WENDELL AMY A. Director 1,980
2026-03-27 ALBAN CARLOS Director 1,980
2026-03-27 DEVORE SUSAN D Director 1,980
2026-03-27 WILSON DARRYL L Director 1,980
2026-03-27 MILY ELIZABETH Director 1,980
MCMILLAN WAYDE D Chief Financial Officer
2026-05-13 9,503 sh
HANSON BRYAN CRAIG Chief Executive Officer
2026-05-13 34,315 sh
KIRBERGER MARCELA A. Officer
2026-05-13 4,488 sh
GOMEZ TAMMY L Officer
2026-05-13 3,960 sh
LANDUCCI AMY Chief Technology Officer
2026-05-13 4,422 sh
WILCOX MARY T Officer
2026-05-13 2,376 sh
HARRINGTON PAUL S Officer
2026-05-13 3,960 sh
EISENBERG GLENN A Director
2026-04-30 3,403 sh
HARRIS BERNARD A JR Director
2026-04-30 3,403 sh
ALBAN CARLOS Director
2026-04-30 3,403 sh
DEVORE SUSAN D Director
2026-04-30 3,403 sh
WILSON DARRYL L Director
2026-04-30 3,403 sh
MILY ELIZABETH Director
2026-04-30 3,403 sh
WEILAND JOHN H Director
2026-04-30 3,403 sh
COX CARRIE SMITH Director
2026-04-30 4,916 sh
MAY KAREN J Director
2026-04-30 3,403 sh
EDWARDS SHIRLEY ANN Director
2026-04-30 3,403 sh
WENDELL AMY MCBRIDE Director
2026-04-30 3,403 sh
EISENBERG GLENN A Director
2026-03-27 1,980 sh
HARRIS BERNARD A JR Director
2026-03-27 1,980 sh
MCBRIDE-WENDELL AMY A. Director
2026-03-27 1,980 sh
ALBAN CARLOS Director
2026-03-27 1,980 sh
DEVORE SUSAN D Director
2026-03-27 1,980 sh
WILSON DARRYL L Director
2026-03-27 1,980 sh
MILY ELIZABETH Director
2026-03-27 1,980 sh